Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DB25FJJ31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,230
Award facts
- Contract value 100% obligated
- $7,229.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This firm fixed price delivery order, valued at $7,229.88, represents a non-set-aside award and is due for completion by August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Monovisc is a viscosupplement injection used in orthopedic and rheumatological applications to provide pain relief and improve joint function, making it a critical medical supply for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. The parent IDC enables AmerisourceBergen Drug Corp to supply pharmaceutical products and medical commodities across multiple therapeutic domains to support Department of Defense health systems worldwide. As a major pharmaceutical distributor, the company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military operations and personnel healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FJJ31?
SPE2DB25FJJ31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FJJ31 worth?
The government has obligated $7,230 on SPE2DB25FJJ31.
Is contract SPE2DB25FJJ31 an order under another contract?
Yes. SPE2DB25FJJ31 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ31 competed?
The extent of competition for SPE2DB25FJJ31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award